This article is more than 5 years old. Information may no longer be current.
FDA, Qualitest Pharmaceuticals recall two lots of Accusure insulin syringes
Lots contain needles that may detach from syringe.
The FDA and Qualitest Pharmaceuticals have announced a voluntary nationwide recall of two lots of Accusure Insulin Syringes.
The syringes in these lots have been found to have needles that can detach from the syringe. When the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe or remain in the skin after an injection.
Qualitest recalled ½ cc and 1 cc 31 G Short Needle syringes with lot numbers 6JCB1 and 7CPT1. The lot number can be found on the white paper backing of each individual syringe. The recalled lots were distributed between January 2007 and June 2008 to wholesalers and retail pharmacies nationwide.
Qualitest is notifying all consumers who received the syringes and arranging for return of any recalled products. Meantime, consumers are encouraged to stop using the recalled lots.
Adverse reactions or quality problems associated with the syringes may be reported to the FDA MedWatch Adverse Event Reporting program.